Department of Neurology, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, 114 16th Street B114-2000, Boston, MA 02129, United States.
J Neurosci Methods. 2012 Mar 15;204(2):221-6. doi: 10.1016/j.jneumeth.2011.11.014. Epub 2011 Dec 2.
The availability of high quality, well-characterized antibodies for molecular and cellular neuroscience studies is important. However, not all available antibodies are rigorously evaluated, nor are limitations of particular antibodies often reported. We have examined a panel of currently available mGluR1 antibodies and have identified which ones are selective for use by western blots and immunocytochemistry. We have also specifically determined whether the antibodies cross-react to recognize mGluR5, by examining (1) tissue from both mGluR1 and mGluR5 knock-out mice and (2) primary cortical cultures, in which mGluR5 is widely expressed but mGluR1 is not. Together, these data provide a baseline characterization of antibodies that can and cannot be reliably used in these types of studies, and will hopefully facilitate and positively impact the research efforts of others studying mGluR1.
用于分子和细胞神经科学研究的高质量、特征良好的抗体的可用性很重要。然而,并非所有可用的抗体都经过严格评估,也没有经常报告特定抗体的局限性。我们已经检查了目前可用的 mGluR1 抗体组,并确定了哪些抗体可用于 Western blot 和免疫细胞化学。我们还通过检查(1)来自 mGluR1 和 mGluR5 敲除小鼠的组织和(2)原代皮质培养物,特异性地确定了这些抗体是否与 mGluR5 发生交叉反应,在这些培养物中广泛表达 mGluR5 但不表达 mGluR1。这些数据共同为可以在这些类型的研究中可靠使用和不能可靠使用的抗体提供了基线特征,希望能促进和积极影响其他研究 mGluR1 的人的研究工作。